Best of Perspectives: Measles' Deadliest Sequelae

Plus: Nitazenes have entered the drug scene

Second Opinions Essays and opinions from our readers, always thought-provoking, sometimes controversial Tuesday, August 20, 2024     This year is flying by! We bring you a special edition of Second Opinions recapping our best performing op-eds from the first half of 2024.   Measles' Deadliest Sequelae     Nitazenes Have Entered the Drug Scene. Now What?     Patients Hitting GLP-1 Plateaus? Here's How to Help     They Rarely Ask for Pain Pills Now     When a Revolutionary Cancer Treatment Causes Cancer     ADVERTISEMENT Recommended For You     Is the First Month of Residency Everything I Thought It Would Be?     I've Seen the Extreme Pain of IUD Insertion     How Worried Should We Be About a Bird Flu Pandemic?       © 2024 MedPage Today, LLC. MedPage Today is among the federally registered trademarks of MedPage Today, LLC, and may not be used by third parties without explicit permission. You have received this email because you have registered to receive emails at www.medpagetoday.com, with the email address: edwardlorilla1986.acciyo123@blogger.com Manage Email Preferences   |    Unsubscribe   |   Terms of Use   |   Privacy Policy Technical Questions: feedback@medpagetoday.com 114 Fifth Avenue 15th Floor New York, NY 10011